| Report Title | Price | Action |
|---|---|---|
| Monoglyceride Lipase (Lysophospholipase Homolog or Lysophospholipase Like or HU K5 or Monoacylglycerol Lipase or MGLL or EC 3.1.1.23) - Drugs in Development, 2021
Monoglyceride Lipase (Lysophospholipase Homolog or Lysophospholipase Like or HU K5 or Monoacylglycerol Lipase or MGLL or EC 3.1.1.23) - Drugs in Devel...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) - Drugs in Development, 2021
Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) - Drugs in Development, 2021 Summary Thyrotropin Receptor (Thyroid Stimulating H...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Inherited Metabolic Disorders (Genetic Disorders) - Drugs in Development, 2021
Inherited Metabolic Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Inherited Metabolic Disorders (Genetic Disorders) - Drugs in ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Tauopathies (Central Nervous System) - Drugs in Development, 2021
Tauopathies (Central Nervous System) - Drugs in Development, 2021 Summary Tauopathies (Central Nervous System) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Malignant Glioma (Oncology) - Drugs in Development, 2021
Malignant Glioma (Oncology) - Drugs in Development, 2021 Summary Malignant Glioma (Oncology) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 90
|
$ 2000 | |
| NAD Dependent Protein Deacetylase Sirtuin 2 (Regulatory Protein SIR2 Homolog 2 or SIR2 Like Protein 2 or SIRT2 or EC 2.3.1.286) - Drugs in Development, 2021
NAD Dependent Protein Deacetylase Sirtuin 2 (Regulatory Protein SIR2 Homolog 2 or SIR2 Like Protein 2 or SIRT2 or EC 2.3.1.286) - Drugs in Development...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) - Drugs in Development, 2021
TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) - Drugs in Development, 2021 Summary TRAF2 and NCK Interacting Protein Kinase (TNIK o...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021
Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 Summary Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| T-Cell Leukemia (Oncology) - Drugs in Development, 2021
T-Cell Leukemia (Oncology) - Drugs in Development, 2021 Summary T-Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 80
|
$ 2000 | |
| Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021
Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021 Summary Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 145
|
$ 2000 | |
| Natural Cytotoxicity Triggering Receptor 1 (Lymphocyte Antigen 94 Homolog or NK Cell Activating Receptor or Natural Killer Cell p46 Related Protein or CD335 or NCR1) - Drugs in Development, 2021
Natural Cytotoxicity Triggering Receptor 1 (Lymphocyte Antigen 94 Homolog or NK Cell Activating Receptor or Natural Killer Cell p46 Related Protein or...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Transcriptional Enhancer Factor TEF-1 (NTEF-1 or Protein GT-IIC or TEA Domain Family Member 1 or Transcription Factor 13 or TEAD1) - Drugs in Development, 2021
Transcriptional Enhancer Factor TEF-1 (NTEF-1 or Protein GT-IIC or TEA Domain Family Member 1 or Transcription Factor 13 or TEAD1) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Human Metapneumovirus Infections (Infectious Disease) - Drugs in Development, 2021
Human Metapneumovirus Infections (Infectious Disease) - Drugs in Development, 2021 Summary Human Metapneumovirus Infections (Infectious Disease) - D...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| T-Cell Lymphomas (Oncology) - Drugs in Development, 2021
T-Cell Lymphomas (Oncology) - Drugs in Development, 2021 Summary T-Cell Lymphomas (Oncology) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 125
|
$ 2000 | |
| Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021
Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021 Summary Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 375
|
$ 2500 | |
| Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021
Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021 Summary Nitric Oxide Synthase (NO Synthase or NOS or EC 1.1...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Transforming Growth Factor (TGF) - Drugs in Development, 2021
Transforming Growth Factor (TGF) - Drugs in Development, 2021 Summary Transforming Growth Factor (TGF) - Drugs in Development, 2021 provides in dept...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021
Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 Summary Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Thromboangiitis Obliterans (Buerger Disease) (Cardiovascular) - Drugs in Development, 2021
Thromboangiitis Obliterans (Buerger Disease) (Cardiovascular) - Drugs in Development, 2021 Summary Thromboangiitis Obliterans (Buerger Disease) (Car...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021
Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021 Summary Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 85
|
$ 2000 |